INEVDAK Trademark

Trademark Overview

On Tuesday, December 7, 2010, a trademark application was filed for INEVDAK with the United States Patent and Trademark Office. The USPTO has given the INEVDAK trademark a serial number of 85192378. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 8, 2014. This trademark is owned by Novartis AG. The INEVDAK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, and for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, ophthalmology, in tissue and organ transplantation, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the treatment of diabetes; anti-infective preparations; antiviral preparations; antibiotics; antifungal preparations; vaccines; diagnostic preparations for medical use
inevdak

General Information

Serial Number85192378
Word MarkINEVDAK
Filing DateTuesday, December 7, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 8, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, and for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, ophthalmology, in tissue and organ transplantation, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the treatment of diabetes; anti-infective preparations; antiviral preparations; antibiotics; antifungal preparations; vaccines; diagnostic preparations for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, December 8, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 8, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 26, 2014EXTENSION 5 GRANTED
Wednesday, April 23, 2014EXTENSION 5 FILED
Wednesday, April 23, 2014TEAS EXTENSION RECEIVED
Thursday, November 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2013EXTENSION 4 GRANTED
Tuesday, October 29, 2013EXTENSION 4 FILED
Tuesday, October 29, 2013TEAS EXTENSION RECEIVED
Saturday, May 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2013EXTENSION 3 GRANTED
Tuesday, April 30, 2013EXTENSION 3 FILED
Tuesday, April 30, 2013TEAS EXTENSION RECEIVED
Saturday, November 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 2, 2012EXTENSION 2 GRANTED
Wednesday, October 31, 2012EXTENSION 2 FILED
Friday, November 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 31, 2012TEAS EXTENSION RECEIVED
Wednesday, May 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 30, 2012EXTENSION 1 GRANTED
Monday, April 30, 2012EXTENSION 1 FILED
Monday, April 30, 2012TEAS EXTENSION RECEIVED
Tuesday, November 1, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 6, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2011PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 2, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 1, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 1, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 1, 2011ASSIGNED TO LIE
Friday, July 22, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 1, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 1, 2011NON-FINAL ACTION E-MAILED
Tuesday, March 1, 2011NON-FINAL ACTION WRITTEN
Tuesday, March 1, 2011ASSIGNED TO EXAMINER
Friday, December 10, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 10, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

inevdak preparations system treatment pharmaceutical disorders prevention diseases diabetes bacteria based